logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Today at 3pm, an important press conference will be held, where the Minister of Commerce will present the situation.

date
23/07/2026
The State Council Information Office will hold a press conference at 3 p.m. on July 23, 2026. Deputy Minister of Commerce Yan Dong will introduce the work and operation of commerce in the first half of 2026, and answer questions from journalists.
Latest
1 m ago
The Australia S&P/ASX 200 index rose 0.7% in early trading, reaching 8,888.70 points.
2 m ago
Changan Automobile (000625.SZ) applied to the Shenzhen Stock Exchange for approval to issue A-shares to specific investors, and the application was approved.
3 m ago
The Nikkei 225 index has increased by 1%.
3 m ago
U.S. stock index futures fell in early Asian trading as Alphabet and Tesla's share prices dropped after releasing their earnings reports.
3 m ago
The pharmaceutical company Galectin Therapeutics-B (01672) will report in oral presentation format at the 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD) that the weight loss effect of ASC36_35 FDC is superior to the combination of eloralintide and tirzepatide based on preclinical data.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.